Articles

No matter the indication, molecule, or therapeutic area, every drug developer working on a parenteral medication needs to answer the same essential question: what’s the best approach to retaining the product’s stability? The answer is critically important from your very...

Packaging is elemental to the safe, effective delivery of virtually every pharmaceutical manufactured. The global delivery of more than 11 billion doses of COVID vaccine to date is testimony to that fact.1 As the last step in drug product finishing,...

Biopharma businesses have made an indisputable impact on our world over the last two years, resulting in a growing strategic role for CDMOs specializing in aseptic fill-finish for injectables – a domain that shows signs of unwavering strength. In...

Oral Solid Dosage Forms Raise the Bar On Pharma Standards The oral route has for long been the most common and convenient of the different delivery routes. Oral Solid Dosage Forms (tablets and capsules) are among the most widely used...

The COVID-19 pandemic pointed to the importance and vulnerability of pharmaceutical supply chains. Consequently, the pharma industry is focusing on establishing more resilient supply chains.This is critical, butimproving the supply chain is irrelevant if the products can’t be used...

Microheterogeneity in seemingly homogenous cell populations plays a key role in determining the pathways pursued by biological systems. Variation in expression of gene products and other processes result in this underlying microheterogeneity. Understanding these variations at the single cell...

For biopharmaceutical companies developing an injectable drug product, the transition from laboratory to in-human trials is one of the most important steps in their molecule’s early development. For organizations at this point in the drug development process, the pivot...